As of 2026-03-13, the Relative Valuation of Arcoma AB (ARCOMA.ST) is 11.44 SEK. This relative valuation is based on P/E multiples. With the latest stock price at 8.00 SEK, the upside of Arcoma AB based on Relative Valuation is 43.0%.
The range of the Relative Valuation is 6.35 - 17.55 SEK.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 28.0x | 24.0x |
| Forward P/E multiples | 17.9x - 22.6x | 20.1x |
| Fair Price | 6.35 - 17.55 | 11.44 |
| Upside | -20.6% - 119.3% | 43.0% |
| Date | P/E |
| 2026-03-12 | 26.32 |
| 2026-03-11 | 26.32 |
| 2026-03-10 | 26.38 |
| 2026-03-09 | 26.32 |
| 2026-03-06 | 28.36 |
| 2026-03-05 | 26.65 |
| 2026-03-04 | 27.44 |
| 2026-03-03 | 26.38 |
| 2026-03-02 | 27.96 |
| 2026-02-27 | 27.96 |
| 2026-02-26 | 26.05 |
| 2026-02-25 | 25.66 |
| 2026-02-24 | 23.95 |
| 2026-02-23 | 25.07 |
| 2026-02-20 | 24.67 |
| 2026-02-19 | 26.19 |
| 2026-02-18 | 27.30 |
| 2026-02-17 | 25.73 |
| 2026-02-16 | 25.00 |
| 2026-02-13 | 25.66 |
| 2026-02-12 | 23.29 |
| 2026-02-11 | 23.75 |
| 2026-02-10 | 24.61 |
| 2026-02-09 | 24.01 |
| 2026-02-06 | 25.00 |
| 2026-02-05 | 25.40 |
| 2026-02-04 | 23.88 |
| 2026-02-03 | 23.82 |
| 2026-02-02 | 24.08 |
| 2026-01-30 | 23.75 |
| 2026-01-29 | 23.88 |
| 2026-01-28 | 24.54 |
| 2026-01-27 | 24.54 |
| 2026-01-26 | 24.28 |
| 2026-01-23 | 24.87 |
| 2026-01-22 | 24.41 |
| 2026-01-21 | 24.08 |
| 2026-01-20 | 24.67 |
| 2026-01-19 | 25.40 |
| 2026-01-16 | 25.40 |
| 2026-01-15 | 25.73 |
| 2026-01-14 | 25.40 |
| 2026-01-13 | 25.07 |
| 2026-01-12 | 26.19 |
| 2026-01-09 | 25.59 |
| 2026-01-08 | 24.67 |
| 2026-01-07 | 24.01 |
| 2026-01-05 | 23.88 |
| 2026-01-02 | 23.69 |
| 2025-12-30 | 24.15 |